Action 002424 GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Guizhou Bailing Group Pharmaceutical Co., Ltd.

Actions

002424

CNE100000PY3

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 29/04/2024 		Varia. 5j. Varia. 1 janv.
6,46 CNY +1,25 % Graphique intraday de Guizhou Bailing Group Pharmaceutical Co., Ltd. -0,77 % -20,35 %
29/04 Guizhou Bailing Group Pharmaceutical Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI
02/02 Guizhou Bailing Group Pharmaceutical Co, Ltd (SZSE:002424) annonce un rachat d'actions pour une valeur de 200 millions CNY. (SZSE:002424) annonce un rachat d'actions pour une valeur de 200 millions CNY. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.
Guizhou Bailing Group Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.
Guizhou Bailing Group Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
Bailing Group Pharma Gets Green Light for Clinical Trial of New Hepatitis B Drug
China steel association says EU carbon tax a new trade barrier, calls for more talks
Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
China’s Steel Consumption Falls 1.5% in January-September Period
China steel supply needs adjusting, industry official says
La UE pondrá en marcha la primera fase del impuesto fronterizo sobre emisiones de CO2
EU to launch first phase of world-first CO2 border tax
Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.
Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback announced on January 9, 2023 has closed with 12,096,900 shares, representing 0.87% for CNY 100.01 million.
Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.
Guizhou Bailing Group Pharmaceutical Co., Ltd. Announces Management Appointments
Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.
Zhejiang Futures Co., Ltd completed the acquisition of 11.17% stake in Guizhou Bailing Group Pharmaceutical Co., Ltd. from Jiang Wei.
Zhejiang Futures Co., Ltd agreed to acquire a 11.17% stake in Guizhou Bailing Group Pharmaceutical Co., Ltd. from Jiang Wei for approximately CNY 210 million.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 002424
  4. Actualités Guizhou Bailing Group Pharmaceutical Co., Ltd.
  5. Autres langues